|Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease|
E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ...
New England Journal of Medicine 361 (17), 1651-1661, 2009
|Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling|
T Herman, A Mirelman, N Giladi, A Schweiger, JM Hausdorff
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2010
|Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition|
A Mirelman, T Herman, M Brozgol, M Dorfman, E Sprecher, A Schweiger, ...
PloS one 7 (6), e40297, 2012
|Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease?|
A Mirelman, I Maidan, T Herman, JE Deutsch, N Giladi, JM Hausdorff
The Journals of Gerontology: Series A 66 (2), 234-240, 2011
|Effects of training with a robot-virtual reality system compared with a robot alone on the gait of individuals after stroke|
A Mirelman, P Bonato, JE Deutsch
Stroke 40 (1), 169-174, 2009
|Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial|
A Mirelman, L Rochester, I Maidan, S Del Din, L Alcock, F Nieuwhof, ...
The Lancet 388 (10050), 1170-1182, 2016
|How does explicit prioritization alter walking during dual-task performance? Effects of age and sex on gait speed and variability|
G Yogev-Seligmann, Y Rotem-Galili, A Mirelman, R Dickstein, N Giladi, ...
Physical therapy 90 (2), 177-186, 2010
|The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?|
O Segev-Jacubovski, T Herman, G Yogev-Seligmann, A Mirelman, ...
Expert review of neurotherapeutics 11 (7), 1057-1075, 2011
|Gait impairments in Parkinson's disease|
A Mirelman, P Bonato, R Camicioli, TD Ellis, N Giladi, JL Hamilton, ...
The Lancet Neurology 18 (7), 697-708, 2019
|Virtual reality for rehabilitation in Parkinson's disease|
K Dockx, EMJ Bekkers, V Van den Bergh, P Ginis, L Rochester, ...
Cochrane Database of Systematic Reviews, 2016
|Differential effects of severe vs mild GBA mutations on Parkinson disease|
Z Gan-Or, I Amshalom, LL Kilarski, A Bar-Shira, M Gana-Weisz, ...
Neurology 84 (9), 880-887, 2015
|Effects of virtual reality training on gait biomechanics of individuals post-stroke|
A Mirelman, BL Patritti, P Bonato, JE Deutsch
Gait & posture 31 (4), 433-437, 2010
|Increased frontal brain activation during walking while dual tasking: an fNIRS study in healthy young adults|
A Mirelman, I Maidan, H Bernad-Elazari, F Nieuwhof, M Reelick, N Giladi, ...
Journal of neuroengineering and rehabilitation 11, 1-7, 2014
|Estimation of step-by-step spatio-temporal parameters of normal and impaired gait using shank-mounted magneto-inertial sensors: application to elderly, hemiparetic …|
D Trojaniello, A Cereatti, E Pelosin, L Avanzino, A Mirelman, ...
Journal of neuroengineering and rehabilitation 11, 1-12, 2014
|The role of the frontal lobe in complex walking among patients with Parkinson’s disease and healthy older adults: an fNIRS study|
I Maidan, F Nieuwhof, H Bernad-Elazari, MF Reelick, BR Bloem, N Giladi, ...
Neurorehabilitation and neural repair 30 (10), 963-971, 2016
|When does walking alter thinking? Age and task associated findings|
JM Srygley, A Mirelman, T Herman, N Giladi, JM Hausdorff
Brain research 1253, 92-99, 2009
|V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial|
A Mirelman, L Rochester, M Reelick, F Nieuwhof, E Pelosin, ...
BMC neurology 13 (1), 1-12, 2013
|Gait alterations in healthy carriers of the LRRK2 G2019S mutation|
A Mirelman, T Gurevich, N Giladi, A Bar‐Shira, A Orr‐Urtreger, ...
Annals of neurology 69 (1), 193-197, 2011
|Feasibility and effects of home-based smartphone-delivered automated feedback training for gait in people with Parkinson's disease: a pilot randomized controlled trial|
P Ginis, A Nieuwboer, M Dorfman, A Ferrari, E Gazit, CG Canning, ...
Parkinsonism & related disorders 22, 28-34, 2016
|The p. L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease|
Z Gan-Or, LJ Ozelius, A Bar-Shira, R Saunders-Pullman, A Mirelman, ...
Neurology 80 (17), 1606-1610, 2013